Safety outcomes in advanced non-small-cell lung cancer patients treated with first-line platinum-based regimens in the United States.
Conclusions: While EMR data have limitations, the real-world safety outcome with individual chemotherapy regimen could be considered for the better selection of platinum-based therapies in NSCLC.
PMID: 31903235 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research
More News: Alimta | Anemia | Avastin | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Docetaxel | Lung Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine | Taxotere | USA Health